Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year ...

Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year ...

ResMed Inc (RMD) reports a robust quarter with 9% revenue growth, strategic product launches, and expansion in key markets ...

Resmed Inc.’s RMD adjusted earnings per share (EPS) in the first quarter of fiscal 2026 were $2.55, up 15.9% year over year.

Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to ...

ResMed Inc. (NYSE: RMD) reported better-than-expected earnings for the first quarter on Thursday. The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of ...

ResMed's first-quarter result broadly met market expectations, though rising margins and potential for further capital ...

Margaret Giles: Hi, I’m Margaret Giles from Morningstar. Many baby boomers will be coming into retirement with most of their assets in tax-deferred accounts, which require withdrawals called required ...

ResMed’s third quarter results aligned with Wall Street’s revenue expectations, while its non-GAAP earnings per share ...

Plus: What’s open at the IRS, the fight over premium tax credits, guidance on OBBBA, Social Security increases, digital taxes and tariffs, Section 179 expenses and more.

Morgans names the large-cap stocks it sees offering the best risk-adjusted returns and more upside over the next 12 months.

The ASX healthcare sector fell for the week ending November 7, 2025, but several names have bucked the trend on positive news ...